Suppr超能文献

联合图像和流式细胞术DNA评估在人类乳腺癌中的疗效:一项基于2024份切除肿瘤标本常规组织病理学材料的方法学研究。

Efficacy of combined image and flow cytometric DNA assessments in human breast cancer: a methodological study based on a routine histopathological material of 2024 excised tumour specimens.

作者信息

Falkmer U G, Hagmar T, Auer G

机构信息

Department of Pathology, Karolinska Institute and Hospital, Stockholm, Sweden.

出版信息

Anal Cell Pathol. 1990 Sep;2(5):297-312.

PMID:2275876
Abstract

In 2024 excised specimens of malignant tumours of the female mammary gland. the nuclear DNA distribution pattern of the neoplastic cells was assessed by means of two procedures. One was image cytometry (ICM); here, all the 2024 samples were assessed. The other was flow cytometry (FCM) where 1336 specimens were analysed. In 829 of the 2024 tumour nodules the results of ICM and FCM could be compared. The efficacy of both techniques alone was about 80%; that of the combination was about 60%. In the ICM procedure the main reason for the reduction of samples was the failure to obtain representative specimens. The losses in the FCM method were due to poor quality of the histograms (too much background noise and too broad coefficients of variation). In addition, in as much as one third of all the cases, no specimens were set aside for FCM assessments. In 16% of the samples, where the results of the ICM assessment could be compared with those of the FCM analyses, completely diverging DNA ploidy patterns were obtained. The discrepancy was caused by differences in the interpretation of the histograms. In addition, the calculations of so-called S-phase fractions from the diploid FCM histograms was found to be associated with methodological errors, further contributing to differences in the DNA assessments by means of ICM and FCM. Nevertheless, it was advantageous to use combined ICM and FCM assessments, particularly in the interpretation of DNA histograms of uncommon types.

摘要

2024年,对女性乳腺恶性肿瘤的切除标本,通过两种方法评估肿瘤细胞的核DNA分布模式。一种是图像细胞术(ICM),对所有2024个样本进行了评估。另一种是流式细胞术(FCM),分析了1336个标本。在2024个肿瘤结节中的829个中,可以比较ICM和FCM的结果。两种技术单独使用的有效性约为80%;联合使用的有效性约为60%。在ICM程序中,样本减少的主要原因是未能获得有代表性的标本。FCM方法中的损失是由于直方图质量差(背景噪声过多和变异系数过宽)。此外,在所有病例中,多达三分之一的病例没有留出标本用于FCM评估。在16%的样本中,ICM评估结果与FCM分析结果可以比较,但获得了完全不同的DNA倍体模式。差异是由直方图解释的差异引起的。此外,发现从二倍体FCM直方图计算所谓的S期分数与方法学误差有关,这进一步导致了通过ICM和FCM进行DNA评估的差异。然而,使用ICM和FCM联合评估是有利的,特别是在解释不常见类型的DNA直方图时。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验